Clinical Trials Browser

Colonic Neoplasms

PRETEXT I Hepatoblastoma

Colorectal Neoplasms

Anal Canal Carcinoma, Anus Neoplasms

Non functioning pancreatic endocrine tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

Adenomatous Polyposis Coli, Polyps

Biliary Tract Neoplasms, Gallbladder Neoplasms, Recurrence

Colorectal Neoplasms

Stomach Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Colonic Neoplasms, Colorectal Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

Biliary Carcinoma

Esophageal Squamous Cell Carcinoma

Colonic Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

Colorectal Neoplasms

Carcinoma, Hepatocellular

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

Metastatic Adenocarcinoma of the Pancreas

Carcinoma, Hepatocellular

Stomach Neoplasms

HER2-positive Gastric Cancer

Carcinoma, Hepatocellular, Liver Neoplasms

Stomach Neoplasms

Gastro-enteropancreatic neuroendocrine tumor, Lymphoma, Follicular

Colorectal Neoplasms

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Colorectal Neoplasms

Adenocarcinoma Of Esophagus

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Colorectal Adenocarcinoma

Pancreatic Neoplasms

Colorectal Adenocarcinoma

Rectal Neoplasms

Colorectal Neoplasms

Adenocarcinoma Of Esophagus

Colorectal Neoplasms

Neoplasm Metastasis, Stomach Neoplasms

Biliary Tract Neoplasms

Rectal Neoplasms

Adenocarcinoma Of Esophagus, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Neoplasms, Stomach Neoplasms

Neoplasms, Colorectal Neoplasms

Adenocarcinoma Of Esophagus

Stomach Neoplasms

Pancreatic Neoplasms

Resectable Colon Cancer

Pancreatic cancer, adult

Stomach Neoplasms

Clinical Trials

Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

SERENTA

AB02

MOUNTAINEER-03

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

FAPI-GO

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

COLOCROSS

A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.

QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer

MK-3475-C66

BATTMAN

Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resection

00-046

KEYNOTE-585

NAPOLI 3

REPLACE

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

EMERALD-2

Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not

NETTER-3

TRIBE-C

STAR-221

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer

A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer

SOLARIS

FOBEAR

HARMONi-GI3

Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

CIME

TOPAZ-1

Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)

HERIZON-GEA-01

CodeBreaK 301

TroFuse-015

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

PRISM-1

Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

KLASS-09